Swiss Investment Surge: Billions Flow into U.S. Amid Tariff Deal

Swiss companies invested $27 billion in the U.S. early in the year, following a tariff reduction agreement between Switzerland and Washington. Prominent Swiss firms like Novartis and Roche are leading the way with significant projects. The investments are part of a pledge to contribute $200 billion over five years.

Swiss companies have made a considerable financial commitment to the United States, investing $27 billion from January to April. This move is tied to a new tariff agreement between Switzerland and the U.S., as reported by NZZ am Sonntag.

The nations agreed on November 14 that Swiss firms would infuse $200 billion into the U.S. economy over five years. This commitment followed a reduction in punitive tariffs by U.S. President Donald Trump, lowering the rates on Swiss goods from 39% to 15%.

Major companies such as Novartis and Roche have announced substantial plans, including a biomedical research center in San Diego, a cancer-drug facility in Texas, and expanded operations in North Carolina. Other firms, like the shipping group MSC, and industrial entities like Pfiffner Group and Elma, are also amplifying their U.S. efforts.